Target intelligence / Profile preview

Sulfapyridine

Molecular classification
Other (Sulfonamide antibacterial), Enzyme inhibitor (specifically, bacterial dihydropteroate synthase inhibitor)
01

Overview

Sulfapyridine is a synthetic **sulfonamide antibacterial agent**, historically known as M&B 693. It was one of the first effective antibiotics against bacterial pneumonia but has largely been replaced by safer alternatives due to its side effect profile. Its primary mechanism is **competitive inhibition of the enzyme dihydropteroate synthetase**, which blocks folic acid synthesis necessary for nucleic acid production in susceptible microorganisms. This action underlies its original use against various infections. Today, sulfapyridine's main clinical relevance is as a metabolite released from the prodrug **sulfasalazine**, which is widely prescribed for chronic inflammatory conditions such as rheumatoid arthritis and inflammatory bowel diseases. In this context, sulfapyridine exerts systemic anti-inflammatory effects by suppressing synthesis of inflammatory mediators and modulating immune cell infiltration at sites of inflammation. The term "Sulfapyridine-mediated immunomodulation" does not refer to a specific molecular target or receptor but rather describes an effect mediated by this small molecule drug/metabolite. Therefore: *It should not be considered a canonical therapeutic target like an enzyme or receptor.* The correct approach would be to reference either "Dihydropteroate synthase" if discussing its antibacterial action or describe it simply as "Sulfapyridine" when referring to its role within sulfasalazine therapy. Notable safety concerns include agranulocytosis risk—leading to discontinuation for most infectious indications—and potential urinary tract complications due to poor water solubility at certain pH levels. When administered via sulfasalazine therapy, additional risks include blood dyscrasias and male infertility.[1][3][6]

Other names
SulphapyridineM&B 693Dagenan
02

Mechanism of action

Competitive inhibition of bacterial dihydropteroate synthetase, blocking folic acid synthesis required for DNA/RNA production in bacteria As a component of sulfasalazine, contributes to systemic immunomodulatory/anti-inflammatory effects by suppressing inflammatory mediators and modulating cytokine secretion

03

Biological functions

Antibacterial activity via inhibition of folic acid synthesis in bacteriaSystemic anti-inflammatory effects when released from sulfasalazine
04

Disease associations

Infection (historically for bacterial infections such as pneumonia)Inflammation and autoimmune disease (as a metabolite of sulfasalazine in inflammatory bowel disease, rheumatoid arthritis, etc.)
05

Safety considerations

Risk of crystallization in the urinary tract due to pH-dependent solubility, potentially causing pain or blockageAgranulocytosis risk is significant and led to decline in use as an antibioticBlood dyscrasia, hepatitis, hypersensitivity reactions; higher risk with sulfur allergy; can cause low sperm count in males when used as part of sulfasalazine therapy
06

Interacting drugs

Sulfasalazine

Beyond the preview

Go deeper on Sulfapyridine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sulfapyridine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call